For the quarter ending 2025-09-30, HLYK has $1,764,557 in assets. $7,197,972 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 10,911 | 20,201 | ||
| Inventory, net | 31,977 | 27,589 | ||
| Prepaid expenses and other current assets | 36,559 | 48,022 | ||
| Contingent sale consideration receivable, current portion | 1,463,518 | 1,463,518 | ||
| Total current assets | 1,542,965 | 1,559,330 | ||
| Total property and equipment, gross | 803,415 | - | ||
| Less accumulated depreciation | 702,256 | - | ||
| Property and equipment, net of accumulated depreciation of 702,256 and 634,839 as of september 30, 2025 and december 31, 2024, respectively | 101,159 | 121,314 | ||
| Deposits, long term portion | - | 13,993 | ||
| Right of use lease assets | 120,433 | 153,813 | ||
| Total assets | 1,764,557 | 1,848,450 | ||
| Accounts payable, accrued expenses and other current liabilities | 785,982 | 806,270 | ||
| Contract liabilities | 47,735 | 155,212 | ||
| Lease liability, current portion | 116,762 | 137,703 | ||
| Derivative financial instruments | 75,732 | 16,285 | ||
| Notes payable and other amounts due to related party, net of unamortized original issue discount of 32,739 and 494,104 as of september 30, 2025 and december 31, 2024, respectively-Related Party | 5,216,072 | 4,574,766 | ||
| Notes payable, current portion, net of unamortized original issue discount of 92,294 and 27,414 as of september 30, 2025 and december 31, 2024, respectively | 293,937 | 291,788 | ||
| Indemnification liability | 143,974 | 143,974 | ||
| Current liabilities held for sale | 64,107 | - | ||
| Total current liabilities | 6,744,301 | 6,125,998 | ||
| Lease liability, long term portion | 3,671 | 16,110 | ||
| Government and other notes payable, long term portion | 450,000 | 458,660 | ||
| Total liabilities | 7,197,972 | 6,600,768 | ||
| Common stock, par value 0.0001 per share, 500,000,000 shares authorized, 2,847,873 and 2,821,877 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 285 | 28,195 | ||
| Series b convertible preferred stock, par value 0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 2,750 | 2,750 | ||
| Common stock issuable, 0.0001 par value 28,162 and 30,632 as of september 30, 2025 and december 31, 2024, respectively | 85,498 | 170,877 | ||
| Additional paid-in capital | 45,246,444 | 44,962,452 | ||
| Accumulated deficit | -50,768,392 | -49,916,592 | ||
| Total shareholders deficit | -5,433,415 | -4,752,318 | ||
| Total liabilities and shareholders deficit | 1,764,557 | 1,848,450 | ||
HealthLynked Corp (HLYK)
HealthLynked Corp (HLYK)